Zemprocitinib sustained clinical responses through Week 76 in rheumatoid arthritis after inadequate response to biologic therapy
Long-term topline results showed sustained clinical responses with zemprocitinib through Week 76 in rheumatoid arthritis after inadequate response to biologic ...
